SNGX - ソリジェニックス (Soligenix Inc.)

SNGXのニュース

   Graft-Versus-Host Disease (GVHD) Market | Share Analysis and Top Companies Neovii Biotech GmbH, Merck & Co., Inc., Astellas Pharma Inc., Soligenix, Inc., Mesoblast Ltd  2020/11/09 19:19:05 OpenPR
Graft-Versus-Host Disease (GVHD) Market is expected to rise gradually to an estimated value of USD 656.00 million by 2026, registering a CAGR of 6.05% in the forecast period of 2019-2026 with the annual sales of USD 410.00 million in the
   Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial Results  2020/08/14 11:00:00 PR Newswire
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing…
   TCOM, PII among premarket gainers  2020/07/28 12:16:54 Seeking Alpha
Eastman Kodak (NYSE:KODK) +190%. Spectrum Pharmaceuticals (NASDAQ:SPPI) +52% on positive poziotinib data in lung cancer. Soligenix (NASDAQ:SNGX) +44% on en
   Thinking about buying stock in Soligenix Inc, Ekso Bionics, SINTX Technologies, AIM ImmunoTech, or Nio Inc?  2020/06/26 13:31:00 PR Newswire
NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNGX, EKSO, SINT, AIM, and NIO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Stock Alert: Soligenix Stock Up 45% In Pre Market  2020/04/16 09:29:00 RTT News
Shares of Soligenix Inc. (SNGX) are soaring over 45% in pre-market today, after the company announced an agreement for the exclusive worldwide license of CoVaccine HT, a novel vaccine adjuvant, from BTG Specialty Pharmaceuticals, a division of Boston Scientific Corp.
   Graft-Versus-Host Disease (GVHD) Market | Share Analysis and Top Companies Neovii Biotech GmbH, Merck & Co., Inc., Astellas Pharma Inc., Soligenix, Inc., Mesoblast Ltd  2020/11/09 19:19:05 OpenPR
Graft-Versus-Host Disease (GVHD) Market is expected to rise gradually to an estimated value of USD 656.00 million by 2026, registering a CAGR of 6.05% in the forecast period of 2019-2026 with the annual sales of USD 410.00 million in the
   Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial Results  2020/08/14 11:00:00 PR Newswire
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing…
   TCOM, PII among premarket gainers  2020/07/28 12:16:54 Seeking Alpha
Eastman Kodak (NYSE:KODK) +190%. Spectrum Pharmaceuticals (NASDAQ:SPPI) +52% on positive poziotinib data in lung cancer. Soligenix (NASDAQ:SNGX) +44% on en
   Thinking about buying stock in Soligenix Inc, Ekso Bionics, SINTX Technologies, AIM ImmunoTech, or Nio Inc?  2020/06/26 13:31:00 PR Newswire
NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNGX, EKSO, SINT, AIM, and NIO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Stock Alert: Soligenix Stock Up 45% In Pre Market  2020/04/16 09:29:00 RTT News
Shares of Soligenix Inc. (SNGX) are soaring over 45% in pre-market today, after the company announced an agreement for the exclusive worldwide license of CoVaccine HT, a novel vaccine adjuvant, from BTG Specialty Pharmaceuticals, a division of Boston Scientific Corp.
   Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial Results  2020/08/14 11:00:00 PR Newswire
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing…
   TCOM, PII among premarket gainers  2020/07/28 12:16:54 Seeking Alpha
Eastman Kodak (NYSE:KODK) +190%. Spectrum Pharmaceuticals (NASDAQ:SPPI) +52% on positive poziotinib data in lung cancer. Soligenix (NASDAQ:SNGX) +44% on en
   Thinking about buying stock in Soligenix Inc, Ekso Bionics, SINTX Technologies, AIM ImmunoTech, or Nio Inc?  2020/06/26 13:31:00 PR Newswire
NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNGX, EKSO, SINT, AIM, and NIO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Stock Alert: Soligenix Stock Up 45% In Pre Market  2020/04/16 09:29:00 RTT News
Shares of Soligenix Inc. (SNGX) are soaring over 45% in pre-market today, after the company announced an agreement for the exclusive worldwide license of CoVaccine HT, a novel vaccine adjuvant, from BTG Specialty Pharmaceuticals, a division of Boston Scientific Corp.
   Soligenix, Inc. Impresses With Statistically Significant Topline Phase 3 Data From SGX301 FLASH Trial; Targets $250 Million CTCL Patient Market  2020/03/20 12:37:00 Yahoo Finance
New York, New York--(Newsfile Corp. - March 20, 2020) - Soligenix, on Thursday, announced positive topline data for its lead CTCL drug candidate, SGX301. The published data demonstrated statistically significant efficacy results in treating this challenging and often debilitating chronic cancer. Additionally

calendar